Baseline
467 results
356 - 455
Cefiderocol- Indinavir
- Retapamulin
- Rilpivirine
- Oritavancin
- Remdesivir
- Outpatient antibiotic therapy (OPAT)
- Baricitinib
- Helicobacter pylori
Raltegravir- Doripenem
- Raltegravir
- Chlamydia trachomatis
- Fostemsavir
- Voriconazole
- Human papillomavirus (HPV)
- Didanosine
- Zidovudine (AZT)
- Tedizolid
- Zidovudine (AZT)
- Voriconazole
- Didanosine
- Ceftazidime/avibactam
- Immune reconstitution inflammatory syndrome (IRIS)
- Coxiella burnetii
- Entecavir
- Remdesivir
- Tenofovir DF
Diabetic Kidney Disease- Substance Use in Diabetes
- Blepharitis
- Entecavir
- Tenofovir DF
Asenapine- Linezolid
- Pre-exposure Prophylaxis
- Initial Regimen
- Atazanavir
- Atazanavir
- Atovaquone
- Antiretroviral Therapy: Treatment-Experienced Patients
- Cryptococcal Meningitis
- DPP-IV Inhibitors
- Atovaquone
- Selective Serotonin Reuptake Inhibitors (SSRI)
- Albuminuria
- Rotavirus
- Ceftolozane/tazobactam
- Baloxavir
- Urinary Tract Infection, Complicated (UTI)
- Mycoplasma pneumoniae
- Cytomegalovirus
- Opioid-Related Disorders
- Female Sexual Dysfunction
- Hepatitis B
- Staphylococcus aureus
- Hepatitis C
- When to Start Therapy: Chronic HIV Infection
- Niacin
- Retroviral Syndrome, Acute
- Nonalcoholic Fatty Liver Disease
- Type 2 Diabetes: Sequencing Therapies
- Impetigo
- Retroviral Syndrome, Acute
- Screening for and Prevention of Infectious Diseases in Special Populations
- Viekira Pak
- Thiazolidinediones
- Key Studies in Diabetes Care: Management of Complications
- Artificial Pancreas
- Prostatitis, Chronic Bacterial
- Mycobacterium abscessus
- Viekira Pak
- Meropenem
- CMV retinitis
- Zoster vaccine
- Immunomodulating Therapies in Type 1 Diabetes
- Mycobacterium leprae
- Leptospira spp.
- Laryngitis
- Pelvic Inflammatory Disease (PID)
- Zoster vaccine
- Parainfluenza virus
- Candida albicans
- Abacavir
- Abacavir
- Coccidioides immitis
- Candida spp.
- Ebola virus
- Toxoplasma gondii
- Dengue Virus